These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3873214)

  • 1. Use of a time-kill technique for susceptibility testing of Trichomonas vaginalis.
    Krieger JN; Dickins CS; Rein MF
    Antimicrob Agents Chemother; 1985 Mar; 27(3):332-6. PubMed ID: 3873214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of metronidazole alone and in combination with clotrimazole against clinical isolates of Trichomonas vaginalis.
    Debbia EA; Campora U; Massaro S; Boldrini E; Schito GC
    J Chemother; 1996 Apr; 8(2):96-101. PubMed ID: 8708753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro susceptibility of Trichomonas vaginalis to metronidazole and treatment outcome in vaginal trichomoniasis.
    Müller M; Lossick JG; Gorrell TE
    Sex Transm Dis; 1988; 15(1):17-24. PubMed ID: 3258675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measuring the in vitro susceptibility of Trichomonas vaginalis to metronidazole: a disk broth method.
    Smith RF; Di Domenico A
    Sex Transm Dis; 1980; 7(3):120-4. PubMed ID: 6969450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacodynamics of metronidazole determined by a time-kill assay for Trichomonas vaginalis.
    Nix DE; Tyrrell R; Müller M
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1848-52. PubMed ID: 7486930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility of Trichomonas vaginalis strains to metronidazole: response to treatment.
    Ralph ED; Darwish R; Austin TW; Smith EA; Pattison FL
    Sex Transm Dis; 1983; 10(3):119-22. PubMed ID: 6359490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug susceptibility testing of anaerobic protozoa.
    Upcroft JA; Upcroft P
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1810-4. PubMed ID: 11353630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of metronidazole-resistant Trichomonas vaginalis in a gynecology clinic.
    Schmid G; Narcisi E; Mosure D; Secor WE; Higgins J; Moreno H
    J Reprod Med; 2001 Jun; 46(6):545-9. PubMed ID: 11441678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycoplasma hominis infection of Trichomonas vaginalis is not associated with metronidazole-resistant trichomoniasis in clinical isolates from the United States.
    Butler SE; Augostini P; Secor WE
    Parasitol Res; 2010 Sep; 107(4):1023-7. PubMed ID: 20652315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Investigation of in vitro metronidazole resistance in the clinical isolates of Trichomonas vaginalis].
    Ertabaklar H; Yaman Karadam S; Malatyalı E; Ertuğ S
    Mikrobiyol Bul; 2016 Oct; 50(4):552-558. PubMed ID: 28124960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Metronidazole resistance test in vitro in strains of Trichomonas vaginalis isolated from clinical material. 2. Proposal for a standard tests].
    Tachezy J; Kulda J
    Cesk Epidemiol Mikrobiol Imunol; 1991 Mar; 40(2):97-104. PubMed ID: 1827367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance of Trichomonas vaginalis to metronidazole: report of the first three cases from Finland and optimization of in vitro susceptibility testing under various oxygen concentrations.
    Meri T; Jokiranta TS; Suhonen L; Meri S
    J Clin Microbiol; 2000 Feb; 38(2):763-7. PubMed ID: 10655382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activities of ciprofloxacin, ofloxacin, norfloxacin and rosoxacin compared with cinoxacin and trimethoprim.
    Digranes A; Dibb WL; Benonisen E
    Chemotherapy; 1985; 31(6):466-71. PubMed ID: 2934234
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Ghosh AP; Aycock C; Schwebke JR
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29439963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vitro studies on the identification of metronidazole resistant strains of Trichomonas vaginalis (author's transl)].
    Meingassner JG; Stockinger K
    Z Hautkr; 1981 Jan; 56(1):7-15. PubMed ID: 6971538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of seventeen antimicrobial agents against Gardnerella vaginalis.
    Shanker S; Toohey M; Munro R
    Eur J Clin Microbiol; 1982 Oct; 1(5):298-300. PubMed ID: 6223813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trichomonas vaginalis prevalence, incidence, risk factors and antibiotic-resistance in an adolescent population.
    Krashin JW; Koumans EH; Bradshaw-Sydnor AC; Braxton JR; Evan Secor W; Sawyer MK; Markowitz LE
    Sex Transm Dis; 2010 Jul; 37(7):440-4. PubMed ID: 20351623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three metronidazole-resistant strains of Trichomonas vaginalis from the United States.
    Müller M; Meingassner JG; Miller WA; Ledger WJ
    Am J Obstet Gynecol; 1980 Dec; 138(7 Pt 1):808-12. PubMed ID: 7004190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study on the in vitro susceptibility of Trichomonas vaginalis to metronidazole.
    Lin PR; Shaio MF
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1994 Feb; 27(1):38-45. PubMed ID: 9747331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of hexadecylphosphocholine (miltefosine) against metronidazole-resistant and -susceptible strains of Trichomonas vaginalis.
    Blaha C; Duchêne M; Aspöck H; Walochnik J
    J Antimicrob Chemother; 2006 Feb; 57(2):273-8. PubMed ID: 16344287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.